Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
REDWOOD SHORES, Calif., March 31, 2016 -- Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today unveiled the March Hacker Intelligence Initiative Report: “Insiders: The Threat is Already Within.” This new report, published by the Imperva Defense Center and based on primary research conducted by Imperva, shows that insider threat events were found in 100 percent of the studied environments and went undetected by in-place security measures.
The Imperva Defense Center conducted the research by using a combination of machine learning-based behavioral analysis and deception technology to live production data and networks. Machine learning was used to analyze detailed activity logs of the data accessed by insiders. Deception technology added context to the analysis by identifying anomalies indicative of compromised end-points and user credentials. This deeper level of insight proved critical for finding true insider threats within a sea of anomalies.
Based on the studied environments and follow-on analysis, the researchers found:
- Insider threat events were present in 100 percent of the studied environments, confirming suspicions that insider abuse of data is routinely undetected.
- Deception technology, deployed to complement behavioral analysis, positively identified insider threats.
- Insider threat incidents were not identified by any existing in-place security infrastructure.
- Identified insider threats spanned malicious, compromised and careless insiders.
- In most cases, insiders took advantage of granted, trusted access to data, rather than trying to directly hack in to databases and file shares.
“Just finding anomalies in user behavior will not solve the insider threat problem,” said Amichai Shulman, Co-founder and CTO of Imperva. “Enterprises need to have granular visibility into which users are accessing data, and more importantly, the actual queries and data accessed by each user. This deep level of insight proved critical to separating actual incidents from anomalies. Imperva CounterBreach allows customers to apply machine learning and deception technology to both user behaviors and the data that users have accessed, which is the key to pinpointing insider threats.”
Imperva CounterBreach, announced today, includes the technologies that the Imperva Defense Center used in this research.
About Imperva
Imperva® (NYSE:IMPV) is a leading provider of cyber security solutions that protect business-critical data and applications. The company’s SecureSphere, CounterBreach, Incapsula and Skyfence product lines enable organizations to discover assets and risks, protect information wherever it lives – in the cloud and on-premises – and comply with regulations. The Imperva Defense Center, a research team comprised of some of the world’s leading experts in data and application security, continually enhances Imperva products with up-to-the-minute threat intelligence, and publishes reports that provide insight and guidance on the latest threats and how to mitigate them. Imperva is headquartered in Redwood Shores, California. Learn more: www.imperva.com, our blog, on Twitter.
© 2016 Imperva, Inc. All rights reserved. Imperva, the Imperva logo, SecureSphere, CounterBreach, Incapsula and Skyfence are trademarks of Imperva, Inc. and its subsidiaries.
Winifred Shum Imperva [email protected] Eskenzi PR [email protected]
